The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lokker, N. A.
Right arrow Articles by Zenke, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lokker, N. A.
Right arrow Articles by Zenke, G.

The Journal of Immunology, Vol 146, Issue 3 893-898, Copyright © 1991 by American Association of Immunologists


ARTICLES

Mapping the epitopes of neutralizing anti-human IL-3 monoclonal antibodies. Implications for structure-activity relationship

NA Lokker, U Strittmatter, C Steiner, B Fagg, P Graff, HP Kocher and G Zenke
Preclinical Research, Sandoz Pharma Ltd., Basle, Switzerland.

The epitopes of neutralizing mAb were mapped in order to identify a receptor binding site on human IL-3 (huIL-3). To initiate this structure and activity analysis, four neutralizing mAb were selected on the basis of preventing rhuIL-3 stimulated proliferation of peripheral blood cells from a patient with chronic myelogenous leukemia (CML). In order to identify continuous epitopes, the neutralizing mAb were assayed in a solid-phase ELISA for their reactivity with either denatured rhuIL-3 or with the peptides generated by digestion of rhuIL- 3 by using two different proteinases. Two of the neutralizing mAb recognized single fragments from both digestions. Amino acid (aa) sequence determination showed that these peptides overlap, defining a region of 22 aa (aa 29 to 50 of the mature rhuIL-3 protein). In a competition ELISA, the two continuous epitopes were shown to be linked to one another and to the two discontinuous epitopes, suggesting that all four neutralizing mAb bind to a discrete region of the IL-3 molecule, which might be involved in binding to the IL-3R.


This article has been cited by other articles:


Home page
Infect. Immun.Home page
L. T. Y. Pang, W. W. S. Kum, and A. W. Chow
Inhibition of Staphylococcal Enterotoxin B-Induced Lymphocyte Proliferation and Tumor Necrosis Factor Alpha Secretion by MAb5, an Anti-Toxic Shock Syndrome Toxin 1 Monoclonal Antibody
Infect. Immun., June 1, 2000; 68(6): 3261 - 3268.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. K. Klein, Y. Feng, C. A. McWherter, W. F. Hood, K. Paik, and J. P. McKearn
The Receptor Binding Site of Human Interleukin-3 Defined by Mutagenesis and Molecular Modeling
J. Biol. Chem., September 5, 1997; 272(36): 22630 - 22641.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1991 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1991 by The American Association of Immunologists, Inc. All rights reserved.